T/JPMA 032-2025 Active Group standards

T/JPMA 032-2025 Technical Specifications for the Detection of Human-derived Drug-Resistant Bacteria in the Intestinal Tract

T/JPMA 032-2025 The technical specifications for detecting resistant bacteria in human gut microbiota can be divided into four categories

Publish Date: 2025-06-24 Implement Date: 2025-07-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/JPMA 032-2025
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: Urban transportation facilities
ICS Name: Other standards related to microbiology
Publish Date: 2025-06-24
Implement Date: 2025-07-01

Scope

Scope: This document specifies the equipment and materials, culture media and reagents, sample collection, storage and transportation, strain isolation and identification, drug susceptibility testing, quality control, result interpretation and reporting, and biosafety requirements for the detection of Enterobacteriaceae bacteria with extended-spectrum β-lactamase in the human gut, carbapenem-resistant bacteria, polymyxin-resistant bacteria, and vancomycin-resistant enterococci. This document is applicable to the detection of Enterobacteriaceae bacteria with extended-spectrum β-lactamase in the human gut, carbapenem-resistant bacteria, polymyxin-resistant bacteria, and vancomycin-resistant enterococci. Main technical content: This document specifies the equipment and materials, culture media and reagents, sample collection, storage and transportation, strain isolation and identification, drug susceptibility testing, quality control, result interpretation and reporting, and biosafety requirements for the detection of Enterobacteriaceae bacteria with extended-spectrum β-lactamase in the human gut, carbapenem-resistant bacteria, polymyxin-resistant bacteria, and vancomycin-resistant enterococci. This document is applicable to the detection of Enterobacteriaceae bacteria with extended-spectrum β-lactamase in the human gut, carbapenem-resistant bacteria, polymyxin-resistant bacteria, and vancomycin-resistant enterococci.

Development Information

Related Standards

Contact Us